RARE - Ultragenyx Pharmaceutical Inc.
21.8
-0.270 -1.239%
Share volume: 2,251,986
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$22.07
-0.27
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-03-2024 | 08-02-2024 | 11-05-2024 | 02-19-2025 | 05-06-2025 | 08-05-2025 | 11-04-2025 | 02-18-2026 | |
| Total revenue | 108.833 M | 147.026 M | 139.494 M | 164.877 M | 139.292 M | 166.496 M | 159.933 M | 207.279 M | |
| Cost of revenue | 17.533 M | 21.280 M | 21.021 M | 16.894 M | 28.662 M | 23.002 M | 27.991 M | 29.345 M | |
| Gross profit | 91.300 M | 125.746 M | 118.473 M | 147.983 M | 110.630 M | 143.494 M | 131.942 M | 177.934 M | |
| 37.73% | -5.78% | 24.91% | -25.24% | 29.71% | -8.05% | 34.86% | |||
| Operating expenses | 256.647 M | 242.107 M | 250.460 M | 270.261 M | 253.569 M | 251.382 M | 302.832 M | 291.217 M | |
| Selling general and admin | 78.160 M | 80.604 M | 80.351 M | 82.495 M | 87.797 M | 86.646 M | 86.620 M | 87.937 M | |
| Research and development | 178.487 M | 161.503 M | 170.109 M | 187.766 M | 165.772 M | 164.736 M | 216.212 M | 203.280 M | |
| Total expenses | 274.180 M | 263.387 M | 250.460 M | 270.261 M | 253.569 M | 251.382 M | 302.832 M | 291.217 M | |
| -3.94% | -4.91% | 7.91% | -6.18% | -0.86% | 20.47% | -3.84% | |||
| Operating income | -165.347 M | -116.361 M | -131.987 M | -122.278 M | -142.939 M | -107.888 M | -170.890 M | -113.283 M | |
| Ebit | -165.347 M | -116.361 M | -128.910 M | -125.884 M | -142.102 M | -105.748 M | -171.933 M | -114.217 M | |
| Pretax income | -170.229 M | -130.740 M | -133.213 M | -133.404 M | -149.770 M | -114.004 M | -179.540 M | -127.686 M | |
| -23.20% | 1.89% | 0.14% | 12.27% | -23.88% | 57.49% | -28.88% | |||
| Income tax | 455.000 K | 858.000 K | 303.000 K | -19.000 K | 1.310 M | 947.000 K | 873.000 K | 870.000 K | |
| Net income basic | -170.684 M | -131.598 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 22.90% | 100.00% | ||||||||
| Net income | -170.684 M | -131.598 M | -133.516 M | -133.385 M | -151.080 M | -114.951 M | -180.413 M | -128.556 M | |
| 22.90% | -1.46% | 0.10% | -13.27% | 23.91% | -56.95% | 28.74% |